Physicochemical and Cytotoxicity Characterization of Injectable Bone Substitute Based on Hydroxyapatite - Chitosan - Streptomycin for Spinal Tuberculosis Cases

Article Preview

Abstract:

Injectable bone substitute (IBS) based on hydroxyapatite, chitosan and streptomycin has been developed succesfully. The IBS was made by mixturing 20% w/v hydroxyapatite and varying the chitosan ratio of 60:40, 65:35, 70:30, 75:25 and adding streptomycin as antibiotic substance. The mixture was added with hydroxyl propyl methylcellulose. The synthesis process was steady and no chemical reaction occurred as proven by Fourier Transform Infrared Spectroscopy (FTIR). The in vitro characterization were acidity (pH) and cytotoxicity test (MTT assay), while the physical characterization performed included injectability test, setting time, and morphology. The acidity test showed that the pH samples reached the human normal pH (6.8-7.4) in seven days. The cytotoxicity test proved that the samples were non-toxic. The repasta test showed that the acidity reached the human pH and could release the IBS pasta around 111-150 seconds. The injectability test indicated that IBS had ability to be injected for 95-96%. The setting time in all samples needed 72-166 minutes when it was injected into human bone scaffold model that was able to coat the pore of its scaffold model which proven by Scanning Electron Microscope (SEM) imaging. The pore size of human bone scaffold model was decreased from ±800 μm into ±120 μm. So, IBS pasta based on hydroxyapatite-chitosan-streptomycin in physicochemical and cytotoxicity behaviour is preferable to be applied for spinal tuberculosis cases.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

133-138

Citation:

Online since:

August 2019

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2019 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

* - Corresponding Author

[1] World Health Organization, GLOBAL TUBERCULOSIS REPORT 2017 (2017).

Google Scholar

[2] J. S. Mehta and S. Y. Bhojraj, Tuberculosis of the thoracic spine. A classification based on the selection of surgical strategies., J. Bone Joint Surg. Br. 83 (2001) 859–863.

DOI: 10.1302/0301-620x.83b6.0830859

Google Scholar

[3] D.-D. Pham, E. Fattal, and N. Tsapis, Pulmonary drug delivery systems for tuberculosis treatment., Int. J. Pharm. 478 (2015) 517–529.

DOI: 10.1016/j.ijpharm.2014.12.009

Google Scholar

[4] Z. Shen, T. Yu, and J. Ye, Microstructure and properties of alendronate-loaded calcium phosphate cement., Mater. Sci. Eng. C. Mater. Biol. Appl. 42 (2014) 303–311.

DOI: 10.1016/j.msec.2014.05.043

Google Scholar

[5] P. Weiss, O. Gauthier, J.-M. Bouler, G. Grimandi, and G. Daculsi, Injectable bone substitute using a hydrophilic polymer, Bone 25 (1999) 67S–70S.

DOI: 10.1016/s8756-3282(99)00146-5

Google Scholar

[6] W. Liu et al. A novel injectable, cohesive and toughened Si-HPMC (silanized-hydroxypropyl methylcellulose) composite calcium phosphate cement for bone substitution., Acta Biomater. 10 (2014) 3335–3345.

DOI: 10.1016/j.actbio.2014.03.009

Google Scholar

[7] A. S. Budiatin, M. Zainuddin, and J. Khotib, Biocompatable composite as gentamicin delivery system for osteomyelitis and bone regeneration, Int. J. Pharm. Pharm. Sci. 6 (2014) 223–226.

Google Scholar

[8] H. N. Maulida, D. Hikmawati, and A. S. Budiatin, Injectable Bone Substitute Paste Based on Hydroxyapatite , Gelatin and Streptomycin for Spinal Tuberculosis, J. Spine 4 (2015) 4–7.

DOI: 10.4172/2165-7939.1000266

Google Scholar

[9] N. M. Alves and J. F. Mano, Chitosan derivatives obtained by chemical modifications for biomedical and environmental applications., Int. J. Biol. Macromol. 43 (2008) 401–414.

DOI: 10.1016/j.ijbiomac.2008.09.007

Google Scholar

[10] E. J. Oswald and J. K. Nielsen, Studies on the Stability of Streptomycin in Solution., Science 105 (1947) 184–185.

Google Scholar

[11] C. Khoswanto, E. Arijani, and P. Soesilawati, Cytotoxicity test of 40, 50 and 60% citric acid as dentin conditioner by using MTT assay on culture cell line, Dent. J. (Majalah Kedokt. Gigi) 41 (2008) 103.

DOI: 10.20473/j.djmkg.v41.i3.p103-106

Google Scholar

[12] A. P. Putra, A. A. Rahmah, N. Fitriana, S. A. Rohim, M. Jannah, and D. Hikmawati, The Effect of Glutaraldehyde on Hydroxyapatite-Gelatin Composite with Addition of Alendronate for Bone Filler Application, J. Biomimetics, Biomater. Biomed. Eng. 37 (2018) 107–116.

DOI: 10.4028/www.scientific.net/jbbbe.37.107

Google Scholar

[13] H.-J. Lee, B. Kim, A. R. Padalhin, and B.-T. Lee, Incorporation of chitosan-alginate complex into injectable calcium phosphate cement system as a bone graft material, Mater. Sci. Eng. C 94 (2019) p.385–392.

DOI: 10.1016/j.msec.2018.09.039

Google Scholar

[14] V. V. Thai and B.-T. Lee, Fabrication of calcium phosphate-calcium sulfate injectable bone substitute using hydroxy-propyl-methyl-cellulose and citric acid., J. Mater. Sci. Mater. Med. 21 (2010) 1867–1874.

DOI: 10.1007/s10856-010-4058-9

Google Scholar

[15] G. Hu, L. Xiao, H. Fu, D. Bi, H. Ma, and P. Tong, Study on injectable and degradable cement of calcium sulphate and calcium phosphate for bone repair.,J. Mater. Sci. Mater. Med. 21 (2010) 627–634.

DOI: 10.1007/s10856-009-3885-z

Google Scholar

[16] A. Iwasawa, M. Ayaki, and Y. Niwano, Cell viability score (CVS) as a good indicator of critical concentration of benzalkonium chloride for toxicity in cultured ocular surface cell lines., Regul. Toxicol. Pharmacol. 66 (2013) 177–183.

DOI: 10.1016/j.yrtph.2013.03.014

Google Scholar